top of page
  • Writer's pictureatharva hingane

Electronic Drug Delivery Systems Market, Global Outlook and Forecast 2023-2030

Electronic drug delivery systems (EDDS) represents an exciting trend in the development of drug delivery systems that are portable, interactive, wirelessly connected and allow patient-administered therapy reducing overall healthcare cost.

This report aims to provide a comprehensive presentation of the global market for Electronic Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Electronic Drug Delivery Systems. This report contains market size and forecasts of Electronic Drug Delivery Systems in global, including the following market information:

  • Global Electronic Drug Delivery Systems Market Revenue, 2018-2023, 2024-2030, ($ millions)

  • Global Electronic Drug Delivery Systems Market Sales, 2018-2023, 2024-2030, (K Units)

  • Global top five Electronic Drug Delivery Systems companies in 2022 (%)

Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-electronic-drug-delivery-systems-forecast-2023-2030-857


The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.

Electronic Wearable Infusion Pumps Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of Electronic Drug Delivery Systems include Medtronic, Novo Nordisk, Insulet, Bayer, United Therapeutics, AstraZeneca, Tandem Diabetes Care, Merck and Amgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Electronic Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Electronic Drug Delivery Systems Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)


  • Global Electronic Drug Delivery Systems Market Segment Percentages, by Type, 2022 (%)

  • Electronic Wearable Infusion Pumps

  • Electronic Autoinjectors

  • Electronic Injection Pens

  • Electronic Inhalers

Global Electronic Drug Delivery Systems Market Segment Percentages, by Application, 2022 (%)


  • Diabetes

  • Multiple Sclerosis

  • Cardiovascular Disease

  • Asthma & COPD

  • Other Indications

Global Electronic Drug Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%)


  • North America

  • US

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Nordic Countries

  • Benelux

  • Rest of Europe

  • Asia

  • China

  • Japan

  • South Korea

  • Southeast Asia

  • India

  • Rest of Asia

  • South America

  • Brazil

  • Argentina

  • Rest of South America

  • Middle East & Africa

  • Turkey

  • Israel

  • Saudi Arabia

  • UAE

  • Rest of Middle East & Africa

The report also provides analysis of leading market participants including:


  • Key companies Electronic Drug Delivery Systems revenues in global market, 2018-2023 (Estimated), ($ millions)

  • Key companies Electronic Drug Delivery Systems revenues share in global market, 2022 (%)

  • Key companies Electronic Drug Delivery Systems sales in global market, 2018-2023 (Estimated), (K Units)

  • Key companies Electronic Drug Delivery Systems sales share in global market, 2022 (%)


  • Medtronic

  • Novo Nordisk

  • Insulet

  • Bayer

  • United Therapeutics

  • AstraZeneca

  • Tandem Diabetes Care

  • Merck

  • Amgen

Chapter 1: Introduces the definition of Electronic Drug Delivery Systems, market overview.

Chapter 2: Global Electronic Drug Delivery Systems market size in revenue and volume.

Chapter 3: Detailed analysis of Electronic Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Electronic Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Electronic Drug Delivery Systems capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

CONTACT US:

276 5th Avenue, New York , NY 10001,United States

International: (+1) 646 781 7170

1 view0 comments

Recent Posts

See All

Comentários


bottom of page